Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141123 · ClinicalTrials.gov registry record
Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
A clinical trial, sponsored by IRCCS San Raffaele.
- Completed
- Registry status
- 741
- Enrollment target
NCT05141123: Completed study, sponsored by IRCCS San Raffaele.
NCT05141123 is a clinical trial that has completed, run by IRCCS San Raffaele. The registered enrollment target is 741 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141123 has completed, sponsored by IRCCS San Raffaele.
- COMPLETED
- Registry status
- 741 participants
- Enrollment target
Study Summary
The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.
Primary Outcome
absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies
Interventions
- PROCEDURE Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 741 participants |
| Start Date | 2022-10-30 |
| Est. Completion | 2023-04-20 |
What the finished NCT05141123 record still lists
NCT05141123 is an observational study that tracks outcomes without assigning an intervention. The registered 741 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for is the first listed.
NCT05141123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05141123 about?
NCT05141123 is a clinical study titled "Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures". The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared ...
What is the current status of trial NCT05141123?
This trial is currently completed. The enrollment target is 741 participants. The study started on 2022-10-30. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT05141123?
The interventions under investigation include: Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for (PROCEDURE).
Who is sponsoring clinical trial NCT05141123?
This trial is sponsored by IRCCS San Raffaele, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05786417 · 741 participants · Phase 4
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
- NCT06556563 · 741 participants · Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
- NCT03963622 · 740 participants · NA
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
- NCT04074135 · 740 participants · Phase 2
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI